Pierre Caouette

Mr. Caouette is Chief Operating Officer of BioAxone BioSciences. He is a serial entrepreneur who has expertise in leading company strategy in various industries that include biotechnology, clean technology, and high technology. Mr. Caouette’s background is in computer science, mechanical/electrical engineering, and aviation. He holds a valid ATPL (Airline Transport Pilot License), having been captain for the 8th largest airline, where his computer and mechanical engineering skills were called upon at a management level. Mr. Caouette was an early entrant to computer technology and founded Hexadecimal Canada Inc. (Hexacan) in 1984. Some of Hexacan routines are still in use today in Microsoft’s Operating Systems. Hexacan was sold to a public company in 1990. After the sale of his company, Mr. Caouette, continued to work as a consultant in the field.

In 2000, Mr. Caouette co-Founded BioAxone Therapeutic (Canada) and lead investor. During his tenure as CEO, Mr. Caouette raised over $15M in financing, grew the company to 35 employees, and oversaw cGMP drug manufacturing. These accomplishments resulted in the company receiving recognition as a “Top Ten Canadian Biotech Company” for three years in a row. He was a member of the Canadian Olympic Sailing Team for 14 years. In 2005, after leaving BioAxone Canada, he sailed around the world on his own boat, before starting a clean technology company in the marine field. Some of the custom “world record type” electric propulsion systems that he developed are still in use today, and he continues to consult in the field. Since joining BioAxone as COO in 2015, BioAxone’s valuation has jumped 7-fold.